image dons

I make a donation

ALPHEUS

Evaluating the effect of a loading dose of Ticagrelor compared to Clopidogrel to decrease ischemic events in patients undergoing a scheduled coronary angioplasty.

Terminée

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

logo étude

objectif

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS) : a randomised, open-label, phase 3b trial

date de réalisation

2017

nombre de patients

1900

nombre de centres participants

International multicentric trial

type de financement

Private (AstraZeneca)

Référence

NCT02617290

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

ALPHEUS conducted by Fonds de Dotation ACTION

Autres études

+

ARCACHON

En cours


To demonstrate the non-inferiority of a strategy of simple clinical follow-up (without non-invasive stress testing) in asymptomatic CAD patients with a prior history of coronary revascularization comp...
+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.
+

BIO-TAVI

En cours


Correlation between the platelet reactivity, the von Willebrand factor and bleeding and thrombotic events occuring during the year following TAVI